Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study
- PMID: 32199977
- DOI: 10.1016/j.anai.2020.03.006
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study
Abstract
Background: Little is known about the measurement properties of Patient-Oriented Scoring Atopic Dermatitis (PO-SCORAD) in adults with atopic dermatitis (AD). Even less is known about how PO-SCORAD performs compared with the Patient-Oriented Eczema Measure (POEM).
Objective: To examine the measurement properties of PO-SCORAD and compare them with those of POEM.
Methods: A prospective dermatology practice-based study of 291 patients with AD (age range, 18-72 years).
Results: PO-SCORAD and POEM were moderately correlated with each other (Spearman ρ = 0.56) and had weak-moderate correlations with the Numeric Rating Scale (NRS) worst itch and average itch, Dermatology Life Quality Index (DLQI), ItchyQOL, Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance (SD) and Sleep-Related Impairment (SRI), Patient Health Questionnaire-9 (PHQ-9), and Eczema Area and Severity Index (EASI) (P < .001). POEM had significantly stronger correlations with DLQI, ItchyQOL, and EASI than did PO-SCORAD. PO-SCORAD and POEM had fair discriminant validity. Changes from baseline in PO-SCORAD and POEM were moderately correlated with each other; were weakly to strongly correlated with NRS worst itch and average itch, DLQI, ItchyQOL, PROMIS SD, PROMIS SRI, PHQ-9, and EASI; and had good test-retest reliability. There was no differential item functioning of items or floor or ceiling effects for PO-SCORAD or POEM. The thresholds for meaningful change for PO-SCORAD and POEM were -15.5 and -5.0, respectively. Median completion times for PO-SCORAD and POEM were 3 minutes and 1 minute, respectively.
Conclusion: PO-SCORAD and POEM had good construct and cross-cultural validity, reliability, and responsiveness in adults with AD and were feasible for use in clinical trials and practice. However, POEM had better measurement properties than PO-SCORAD.
Copyright © 2020 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Validation of five patient-reported outcomes for atopic dermatitis severity in adults.Br J Dermatol. 2020 Jan;182(1):104-111. doi: 10.1111/bjd.18002. Epub 2019 Jul 24. Br J Dermatol. 2020. PMID: 30972740
-
Measurement properties of the Patient-Reported Outcomes Information System (PROMIS® ) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.Br J Dermatol. 2020 Nov;183(5):891-898. doi: 10.1111/bjd.18978. Epub 2020 May 10. Br J Dermatol. 2020. PMID: 32107772
-
Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients.Ann Allergy Asthma Immunol. 2020 Mar;124(3):261-266. doi: 10.1016/j.anai.2019.12.002. Epub 2019 Dec 9. Ann Allergy Asthma Immunol. 2020. PMID: 31830585
-
Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.J Allergy Clin Immunol. 2013 Dec;132(6):1337-47. doi: 10.1016/j.jaci.2013.07.008. Epub 2013 Sep 12. J Allergy Clin Immunol. 2013. PMID: 24035157
-
Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.Curr Med Res Opin. 2021 Aug;37(8):1295-1301. doi: 10.1080/03007995.2021.1933929. Epub 2021 Jun 11. Curr Med Res Opin. 2021. PMID: 34027753
Cited by
-
Reducing disparities in the care of atopic dermatitis.Arch Dermatol Res. 2024 Oct 15;316(10):688. doi: 10.1007/s00403-024-03272-x. Arch Dermatol Res. 2024. PMID: 39404903 Review.
-
Risk factors for food sensitization in children with atopic dermatitis: a single-center cross-sectional study.Zhongguo Dang Dai Er Ke Za Zhi. 2022 Aug 15;24(8):887-893. doi: 10.7499/j.issn.1008-8830.2202098. Zhongguo Dang Dai Er Ke Za Zhi. 2022. PMID: 36036127 Free PMC article. Chinese, English.
-
Patient-reported outcome (PRO) instruments for disease severity and quality of life in patients with atopic dermatitis: a systematic review of English and Chinese literature.Ann Transl Med. 2022 Aug;10(16):906. doi: 10.21037/atm-22-3164. Ann Transl Med. 2022. PMID: 36111032 Free PMC article. Review.
-
Ethnicity, Race and Skin Color: Challenges and Opportunities for Atopic Dermatitis Clinical Trials.J Clin Med. 2023 Jun 1;12(11):3805. doi: 10.3390/jcm12113805. J Clin Med. 2023. PMID: 37297999 Free PMC article. Review.
-
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice.Am J Clin Dermatol. 2022 Jul;23(4):459-468. doi: 10.1007/s40257-022-00697-w. Epub 2022 May 31. Am J Clin Dermatol. 2022. PMID: 35639253 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials